Emilia Hollingshed, 1, courageously fights a rare form of germ cell cancer, inspiring her family with every step of her ...

A major risk factor for testicular cancer is an undescended testicle. In normal development, the testes fall or descend from ...

Natera’s fair value estimate has been raised to $202.50 from $193.80, reflecting renewed confidence in the company’s growth trajectory. The price target increase highlights optimism about Natera’s ...

Holding both clinics and their respective doctors jointly liable, the consumer panel directed them to pay a total ...

As a result of a domestic research team reclassifying the diagnosis of pediatric malignant brain tumors according to the ...

Natera Inc. (NASDAQ: NTRA) is one of the best growth stocks to buy now. On September 30, Natera announced the publication of ...

Cancer has become a serious problem in today's life, involving more than 200 types. Know how small changes and symptoms can ...

Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...